One of biggest takeovers so far this year will create a global company with annual revenues of roughly $32 billion.

Kenvue stock share price today shows a major surge after Kimberly-Clark announced plans to buy Kenvue for over $40 billion.

President Donald Trump has claimed Kenvue’s pain reliever is a potential cause of autism, despite clear evidence.

Overview DeFi traders in 2025 rely on advanced DeFi tools for analytics, automation, and MEV protection in decentralized ...

BTC holds near $110K and Ethereum trades around $3,900 as liquidations ease and market makers report clients slowly ...

What should you do with these blue chips? Let's see what one analyst is saying about them. The post Buy, hold, sell: Amcor, ...

Join us for an exclusive webinar where we unveil our new Python API designed to streamline trading as a price taker in FX ...

Gate’s new private wealth management gives crypto investors institutional-level custody, full portfolio oversight, and ...

CHICAGO, Oct. 30, 2025 /PRNewswire/ — Cboe Global Markets, Inc. (Cboe: CBOE), the world’s leading derivatives and securities ...

Get key insights from Option Care Health’s Q3 2025 earnings call—revenue growth, raised guidance, biosimilar trends, and strategies.

CHICAGO, Oct. 30, 2025 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), the world's leading derivatives and securities ...

A wave of bullish options trading has amplified the U.S. stock market's advance toward another major milestone and left ...